CCEW Charity Commission profile

LUNG CANCER RESEARCH

Registered charity 1101823 · organisation 4004052

01 Identity

Registration and reporting

Registration status
Registered
Reporting status
Submission Received
Charity type
Trust
Registered
29 January 2004
Removed
Not supplied
Financial period
1 January 2025 – 31 December 2025
Latest income
£0
Latest expenditure
£0
Gift Aid
No
Owns or uses land
No
In administration
No
Insolvent
No
CIO
No

Public contact address: LUNG CANCER RESEARCH, 2nd Floor, 168 Shoreditch High Street, London, E1 6RA

02 Activities

What the charity does

Fundraising related to lung cancer research.

03 Official extract

Charity Annual Return History

Fin Period Start Date
1 January 2025
Fin Period End Date
31 December 2025
Ar Cycle Reference
AR25
Reporting Due Date
31 October 2026
Date Annual Return Received
9 October 2026
Total Gross Income
£0
Total Gross Expenditure
£0
Fin Period Start Date
1 January 2024
Fin Period End Date
31 December 2024
Ar Cycle Reference
AR24
Reporting Due Date
31 October 2025
Date Annual Return Received
21 April 2026
Total Gross Income
£0
Total Gross Expenditure
£0
Fin Period Start Date
1 January 2023
Fin Period End Date
31 December 2023
Ar Cycle Reference
AR23
Reporting Due Date
31 October 2024
Date Annual Return Received
21 April 2026
Total Gross Income
£0
Total Gross Expenditure
£0
Fin Period Start Date
1 January 2022
Fin Period End Date
31 December 2022
Ar Cycle Reference
AR22
Reporting Due Date
31 October 2023
Date Annual Return Received
31 October 2023
Total Gross Income
£11,960
Total Gross Expenditure
£6,661
Fin Period Start Date
1 January 2021
Fin Period End Date
31 December 2021
Ar Cycle Reference
AR21
Reporting Due Date
31 October 2022
Date Annual Return Received
13 June 2022
Date Accounts Received
13 June 2022
Total Gross Income
£161,800
Total Gross Expenditure
£109,348

04 Official extract

Charity Annual Return Parta

Latest Fin Period Submitted Ind
No
Fin Period Order Number
4
Ar Cycle Reference
AR22
Fin Period Start Date
1 January 2022
Fin Period End Date
31 December 2022
Ar Due Date
31 October 2023
Ar Received Date
31 October 2023
Total Gross Income
£11,960
Total Gross Expenditure
£6,661
Charity Raises Funds From Public
No
Grant Making Is Main Activity
Yes
Charity Receives Govt Funding Contracts
No
Charity Receives Govt Funding Grants
No
Charity Has Trading Subsidiary
No
Does Trustee Receive Any Benefit
No
Trustee Resigned Employment
No
Employees Salary Over 60k
No
Count Volunteers
0
Latest Fin Period Submitted Ind
No
Fin Period Order Number
5
Ar Cycle Reference
AR21
Fin Period Start Date
1 January 2021
Fin Period End Date
31 December 2021
Ar Due Date
31 October 2022
Ar Received Date
13 June 2022
Total Gross Income
£161,800
Total Gross Expenditure
£109,348
Charity Raises Funds From Public
Yes
Charity Professional Fundraiser
No
Charity Commercial Participator
No
Grant Making Is Main Activity
Yes
Charity Receives Govt Funding Contracts
No
Charity Receives Govt Funding Grants
No
Charity Has Trading Subsidiary
No
Does Trustee Receive Any Benefit
No
Trustee Resigned Employment
No
Employees Salary Over 60k
No
Count Volunteers
0

05 Official extract

Charity Area Of Operation

Geographic Area Type
Region
Geographic Area Description
Throughout England And Wales
Welsh Ind
No

06 Official extract

Charity Classification

Classification Code
302
Classification Type
How
Classification Description
Makes Grants To Organisations
Classification Code
203
Classification Type
Who
Classification Description
People With Disabilities
Classification Code
308
Classification Type
How
Classification Description
Sponsors Or Undertakes Research
Classification Code
103
Classification Type
What
Classification Description
The Advancement Of Health Or Saving Of Lives

07 Official extract

Charity Event History

Charity Name
LUNG CANCER RESEARCH
Charity Event Order
1
Event Type
Standard registration
Date Of Event
2004-01-29T00:00:00

08 Official extract

Charity Governing Document

Governing Document Description
TRUST DEED DATED 20 JANUARY 2004.
Charitable Objects
TO PRESERVE AND PROTECT HEALTH BY PROMOTING AND FUNDING CLINICAL LABORATORY AND EPIDEMIOLOGICAL RESEARCH INTO THE CAUSES PREVENTION AND TREATMENT OF LUNG CANCER.
Area Of Benefit
NATIONAL